INDV - Indivior Pharmaceuticals Inc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$44.67
DETAILS
HIGH:
$50.00
LOW:
$36.00
MEDIAN:
$48.00
CONSENSUS:
$44.67
UPSIDE:
19.02%
About Indivior Pharmaceuticals Inc (https://www.indivior.com)
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Joseph J. Ciaffoni | Chief Executive Officer & Director | 1971 | $3,551,792 USD |
| Patrick A. Barry | Chief Commercial Officer | 1968 | $2,071,194 USD |
| Christian Heidbreder | Chief Scientific Officer | 1963 | $1,492,872 USD |
| Ryan Preblick | Chief Financial Officer | 1976 | $1,289,326 USD |
| Jeffrey W. Burris | Chief Legal Officer | 1972 | $1,183,354 USD |
| Alice G. Givens | Company Secretary | 1974 | – |
| Angela Colon-Mahoney | Chief Human Resources Officer | 1976 | – |
| Hillel West | Chief Manufacturing & Supply Officer | 1969 | – |
| Jason Thompson | Vice President of Investor Relations | – | – |
| Kevin L. Espinoza | Chief Integrity & Compliance Officer | – | – |
| Vanessa Procter | Executive Vice President of Corporate Affairs | – | – |
| Vishal Kalia | Chief Strategy & Operating Officer | 1982 | – |